Dr. Khalid Shah is an Associate Professor at Harvard Medical School and heads the Molecular Neurotherapy and Imaging Laboratory at Massachusetts General Hospital in Boston, MA. He is also the Director of the Stem Cell Therapeutics and Imaging program in MGH’s Center for Translational Research, and is a Principal Faculty at Harvard Stem Cell Institute in Boston.
In recent years, Dr. Shah and his team have pioneered major developments in the cancer research field, successfully developing therapeutic stem cells for cancer, particularly brain tumors. These studies have been published in a number of very high impact journals like Nature Neuroscience, PNAS, JNCI, Stem Cells, Lancet Oncology and Nature Reviews Cancer validating the use of therapeutic stem cells for cancer therapy. The potential of developing novel cancer therapies in his laboratory has been recognized by many cancer alliances and associations. Based on this, he has received the young investigator award from Alliance for Cancer Gene Therapy (ACGT), Research fellow award from American Cancer Society (ACS), Innovation awards from James McDonnell Foundation, American Brain Tumor Association (ABTA), Goldhirsh Foundation, and American Association of Radiology. Additionally, Dr. Shah has participated in the training of numerous undergraduate, graduate students and residents at MGH, and the potential of his mentoring has been recognized by Harvard Medical School, who recently awarded him the Harvard Young Mentor Award.
Dr. Shah’s laboratory has achieved international recognition and has recently launched an outreach program to create public awareness of the fervent need for effective brain tumor treatments, and the current research on the cusp of clinical translation that would yield paramount progress for cancer patients. Amongst Dr. Shah’s recently published works are two books featuring current groundbreaking insights into stem cell therapies for cancer.